Biotechnology, Scientist pipetting sample into a multi well plate.

Proteogenomics Consortium Launched by Seer, Discovery Sciences, SCIEX

According to the companies, the consortium will create an infrastructure capable of analyzing and cataloging one billion peptides each year, data which should lead to the identification of new protein variants and novel biomarkers, as targets for the development of potential new therapies.
Woman sitting in front of laptop with head in hands

New Biomarker Found for Depression and Antidepressant Response

Researchers have developed a test that can not only indicate the presence of depression, but it can also indicate therapeutic response with a single biomarker called adenylyl cyclase.
Image to signify drugs designed by artificial intelligence.

Parkinson’s Drug Discovery Collaboration Between Astrogen, Iktos to Leverage AI Platform

Under the terms of the agreement, Iktos will apply its generative learning algorithms which seek to identify new molecular structures with the potential to address a novel target in Parkinson's disease.
The NIH and the Prostate Cancer Foundation (PCF) have launched a study designed to investigate genetic and environmental factors related to aggressiveness of prostate cancer in African-American men

Tumor Growth Inhibited by Disrupting Chromatin Accessibility, Enhancer Addiction

The researchers have found a way to degrade components of SWI/SNF, a chromatin remodeling complex. These components are ATPases that provide the energy SWI/SNF needs to unwrap DNA and expose enhancer elements that crank up the expression of cancer-driving genes.
Autism spectrum disorder, conceptual illustration

Brain Protein Identified as Potential Autism Biomarker

The researchers analyzed the cerebrospinal fluid of individuals with autism and epilepsy, and in mouse models. Previous studies have analyzed the cerebrospinal fluid from patients with Alzheimer’s and Parkinson’s diseases to help diagnose disease and measure response to treatment, but this study is the first to show the protein as a biomarker in autism.
Analyzing Stock

Digital Solutions to Alleviate NASH Clinical Trial Challenges

This Inside Precision Medicine webinar, sponsored by ICON, will focus on the ability of digital technologies, including magnetic resonance imaging (MRI), magnetic resonance elastography (MRE), and whole slide imaging (WSI), to address some of these challenges.
Most cases of colorectal cancer evade early detection

Better Biomarker Choice Could Benefit Colorectal Cancer Patients

Colorectal cancer patients may have more drug options if a systems approach to biomarker identification is used, suggests research from the Salk Institute for Biological Studies.
Prostate cancer, illustration

Imaging Technique Improves Risk Stratification in High-Risk Prostate Cancer

Research suggests prostate-specific membrane antigen positron emission tomography/computed tomography can detect low-volume, non-localized prostate cancer not seen with conventional imaging and improve prognosis prediction.
Uterus Cancer

Comprehensive Cell Atlas Expands Knowledge of Uterine Cancer

The first in-depth reference map of the uterus to collect both single cell and spatial transcriptomic data reveals new insights into the cellular make up of endometrial cancers and adds to the Human Cell Atlas.
Coronavirus RNA strand

Weill Cornell Creates New Center to Study RNA Modifications with $12M from NHGRI

One of the CEGS’s early projects will be led by Jaffrey to map the functional modifications that occur across the “transcriptome,” the complete set of all the mRNAs in a cell.